Journal Mobile Options
Table of Contents
Vol. 26, No. 4, 2008
Issue release date: October 2008
Dement Geriatr Cogn Disord 2008;26:306–313

Neural Correlates of the Clock Drawing Test Performance in Alzheimer’s Disease: A FDG-PET Study

Lee D.Y. · Seo E.H. · Choo I.H. · Kim S.G. · Lee J.S. · Lee D.S. · Jhoo J.H. · Kim K.W. · Youn J.C. · Woo J.I.
aDepartment of Neuropsychiatry and Clinical Research Institute, and bDepartment of Nuclear Medicine, Seoul National University Hospital, and cNeuroscience Research Institute, Medical Research Center and dInterdisciplinary Program in Cognitive Science, Seoul National University, Seoul, Departments of Psychiatry, eSoon Chun Hyang University Hospital, Bucheon, and fKangwon National University Hospital, Chuncheon, and Departments of Neuropsychiatry, gSeoul National University Bundang Hospital, Seongnam, and hKyunggi Provincial Hospital for the Elderly, Yongin, Korea

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background/Aim: This study aimed to identify the functional neuroanatomical correlates of impaired clock drawing test (CDT) performance in patients with Alzheimer’s disease (AD). Method: The CDT was administered to 71 patients with AD, and regional cerebral glucose metabolism (rCMglc) was measured by positron emission tomography (PET). Correlations between CDT scores and rCMglc were examined on a voxel-by-voxel basis. Results: Significant positive correlations were found between CDT performance and rCMglc in the right inferior parietal lobule and right posterior cingulate cortex. Conclusion: These results provide the first PET evidence that poor CDT performance in patients with AD is closely related to the functional decline in the right hemisphere, especially the right parietal cortex.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Rouleau I, Salmon DP, Butters N: Longitudinal analysis of clock drawing in Alzheimer’s disease patients. Brain Cogn 1996;31:17–34.
  2. Tuokko H, Hadjistavropoulos T, Miller JA, Beattie BL: The clock test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease. J Am Geriatr Soc 1992;40:579–584.
  3. Mendez MF, Ala T, Underwood KL: Development of scoring criteria for the clock drawing task in Alzheimer’s disease. J Am Geriatr Soc 1992;40:1095–1099.
  4. Sunderland T, Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA, Grafman JH: Clock drawing in Alzheimer’s disease. A novel measure of dementia severity. J Am Geriatr Soc 1989;37:725–729.
  5. Freedman M, Leach L, Kaplan E, Winocur G, Shulman K, Delis DC: Clock Drawing: A Neuropsychological Analysis, ed 3. New York, Oxford University Press, 1994.
  6. Nagahama Y, Okina T, Suzuki N, Nabatame H, Matsuda M: Neural correlates of impaired performance on the clock drawing test in Alzheimer’s disease. Dement Geriatr Cogn Disord 2005;19:390–396.
  7. Libon DJ, Malamut BL, Swenson R, Sands LP, Cloud BS: Further analyses of clock drawings among demented and nondemented older subjects. Arch Clin Neuropsychol 1996;11:193–205.
  8. Rouleau I, Salmon DP, Butters N, Kennedy C, McGuire K: Quantitative and qualitative analyses of clock drawings in Alzheimer’s disease and Huntington’s disease. Brain Cogn 1992;18:70–87.
  9. Ueda H, Kitabayashi Y, Narumoto J, Nakamura K, Kita H, Kishikawa Y, Fukui K: Relationship between clock drawing test performance and regional cerebral blood flow in Alzheimer’s disease: a single photon emission computed tomography study. Psychiatry Clin Neurosci 2002;56:25–29.
  10. Cahn-Weiner DA, Sullivan EV, Shear PK, Fama R, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A: Brain structural and cognitive correlates of clock drawing performance in Alzheimer’s disease. J Int Neuropsychol Soc 1999;5:502–509.
  11. Lezac MD, Howieson DB, Loring DW: Neuropsychological Assessment, ed 4. New York, Oxford University Press, 2004.
  12. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239–259.
  13. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
  14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
  15. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, Lee KH, Kim SY, Han SH, Woo JI: Development of the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment battery. J Gerontol Psychol Sci 2002;57:47–53.
  16. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 1989;39:1159–1165.
  17. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566–572.
  18. Todd ME, Dammers PM, Adams SG Jr, Todd HM, Morrison M: An examination of a proposed scoring procedure for the clock drawing test: reliability and predictive validity of the clock scoring system (CSS). Am J Alzheimer’s Dis 1995;10:22–26.
  19. Lee DY, Lee KU, Lee JH, Kim KW, Jhoo JH, Kim SY, Yoon JC, Woo SI, Ha J, Woo JI: A normative study of the CERAD neuropsychological assessment battery in the Korean elderly. J Int Neuropsychol Soc 2004;10:72–81.
  20. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ: Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995;2:189–210.

    External Resources

  21. Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RSJ: Spatial registration and normalization of images. Hum Brain Mapp 1995;2:165–169.

    External Resources

  22. Minoshima S, Frey KA, Foster NL, Kuhl DE: Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 1995;19:541–547.
  23. Talairach J, Tournoux P: Co-Planar Stereotaxic Altlas of the Human Brain. New York, Thieme, 1988.
  24. Saumier D, Chertkow H: Semantic memory. Curr Neurol Neurosci Rep 2002;2:516–522.
  25. Moscovitch M, Rosenbaum RS, Gilboa A, Addis DR, Westmacott R, Grady C, McAndrews MP, Levine B, Black S, Winocur G, Nadel L: Functional neuroanatomy of remote episodic, semantic and spatial memory: a unified account based on multiple trace theory. J Anat 2005;207:35–66.
  26. Bohbot VD, Allen JJB, Nadel L: Memory deficits characterized by patterns of lesions to the hippocampus and parahippocampal cortex. Ann NY Acad Sci 2000;911:355–368.
  27. Johnsrude IS, Owen AM, Crane J, Milner B, Evans AC: A cognitive activation study of memory for spatial relationships. Neuropsycholgia 1999;37:829–841.
  28. Bohbot VD, Kalina M, Stepankova K, Spackova N, Petrides M, Nadel L: Spatial memory deficits in patients with lesions to the right hippocampus and to the right parahippocampal cortex. Neuropsychologia 1998;36:1217–1238.
  29. Owen AM, Milner B, Petrides M, Evans AC: Memory for object features versus memory for object location: a positron-emission tomography study of encoding and retrieval processes. Proc Natl Acad Sci USA 1996;93:9212–9217.
  30. Ungerleider LG, Haxby JV: ‘What’ and ‘where’ in the human brain. Curr Opin Neurobiol 1994;4:157–165.
  31. Förstl H, Burns A, Levy R, Cairns NL: Neuropathologial basis for drawing disability (constructional apraxia) in Alzheimer’s disease. Psychol Med 1993;23:623–629.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50